Development of a pharmacodynamic model for HIV treatment with nucleoside reverse transcriptase and protease inhibitors
- 1 November 2002
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 56 (2) , 115-127
- https://doi.org/10.1016/s0166-3542(02)00103-1
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- The Challenge of Viral Reservoirs in HIV-1 InfectionAnnual Review of Medicine, 2002
- Clinical pharmacologic considerations for HIV-1 protease inhibitorsCurrent Infectious Disease Reports, 2001
- Benchmarks for antiretroviral therapyJournal of Clinical Investigation, 2000
- How does HIV cause AIDS? The homing theoryMolecular Medicine Today, 2000
- Clinical Trial Simulation in Drug DevelopmentPharmaceutical Research, 2000
- HIV resistance to zidovudine: the role of pyrophosphorolysisDrug Resistance Updates, 1999
- Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesisAIDS, 1999
- Virus dynamics and drug therapyProceedings of the National Academy of Sciences, 1997
- Kinetics of Response in Lymphoid Tissues to Antiretroviral Therapy of HIV-1 InfectionScience, 1997
- The effect of zidovudine dose on the formation of intracellular phosphorylated metabolitesAIDS, 1996